Suppr超能文献

通过联合抗细胞因子疗法使一名诊断延迟且患有难治性川崎病的婴儿巨大动脉瘤完全消退:病例报告及类似病例回顾

Complete Regression of Giant Aneurysms in an Infant with Delayed Diagnosis and Refractory Kawasaki Disease via Combination Anticytokine Therapy: Case Report and Review of Similar Cases.

作者信息

Williams Maegan, Nagaraju Lakshmi, Gorelik Mark

机构信息

Division of General Pediatrics, Children's Hospital of San Antonio, Baylor College of Medicine, 333 N Santa Rosa St, San Antonio, TX, USA.

Division of Cardiology, Children's Hospital of San Antonio, Baylor College of Medicine, 333 N Santa Rosa St, San Antonio, TX, USA.

出版信息

Case Rep Rheumatol. 2020 Mar 28;2020:6249013. doi: 10.1155/2020/6249013. eCollection 2020.

Abstract

BACKGROUND

Kawasaki disease (KD) is an inflammatory vasculitis and is the most common cause of acquired childhood heart disease in developed countries. Current treatment with intravenous immunoglobulin (IVIG) is often ineffective in patients with delayed or refractory disease. We present a case of combination anticytokine therapy in an infant with delayed and refractory KD. . A 3-month-old infant presented with refractory KD with giant aneurysms after a delayed diagnosis of one month. Use of combination anticytokine therapy led to resolution of giant aneurysms over approximately 6 months.

CONCLUSIONS

Our case is unique in effective use of anticytokine therapy in very delayed disease with giant aneurysms. Additionally, we review other cases for a broader perspective. Prospective study of anticytokine therapy for patients with giant aneurysms may be warranted.

摘要

背景

川崎病(KD)是一种炎症性血管炎,是发达国家儿童后天性心脏病最常见的病因。目前静脉注射免疫球蛋白(IVIG)治疗对疾病延迟或难治的患者往往无效。我们报告一例对延迟和难治性KD婴儿采用联合抗细胞因子治疗的病例。一名3个月大的婴儿在延迟诊断1个月后出现伴有巨大动脉瘤的难治性KD。联合抗细胞因子治疗使巨大动脉瘤在大约6个月内消退。

结论

我们的病例在对伴有巨大动脉瘤的极延迟疾病有效使用抗细胞因子治疗方面具有独特性。此外,我们从更广泛的角度回顾了其他病例。对伴有巨大动脉瘤的患者进行抗细胞因子治疗的前瞻性研究可能是必要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eecc/7142349/1140770a8fdb/CRIRH2020-6249013.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验